

CLASSIFICATION: DUAL GLP-1/GLUCAGON RECEPTOR AGONIST
ACTIVE SUBSTANCE: SURVODUTIDE
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 6-8 DAYS
DOSAGE: 0.3-2.4 MG WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT COMMON
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
Stealth Labs Survodutide 10 mg offers a cutting-edge dual GLP-1 and glucagon receptor agonist peptide, crafted for research into advanced weight management, fat metabolism, and metabolic health. Each 2 mL vial contains 10 mg of Survodutide, manufactured under strict research-grade quality standards.
Survodutide is a dual-action peptide targeting both GLP-1 and glucagon receptors. Research suggests that Survodutide promotes significant weight loss, enhances fat metabolism, improves glucose regulation, and boosts energy expenditure in metabolic research models [Clinical Study].
Research protocols typically involve subcutaneous injections administered weekly. Starting doses in studies usually range from 0.3 mg to 2.4 mg per week, titrated gradually based on study goals. Professional supervision is recommended during peptide research.
Complement your research by stacking Survodutide with Cagrilintide from Stealth Labs USA for enhanced weight management protocols. Discover more premium research peptides in the Stealth Labs USA Peptides section.
Survodutide is studied for appetite suppression, fat loss promotion, glucose regulation, and increased energy expenditure through dual GLP-1 and glucagon receptor activity.
Research protocols usually start with 0.3-1.2 mg weekly administered via subcutaneous injection, with gradual titration based on research objectives and tolerance.
Survodutide has shown a favorable safety profile in research studies. Mild side effects such as gastrointestinal discomfort may occur initially, but generally resolve with dosage adjustment.
Authentic Survodutide 10 mg by Stealth Labs USA is available in our Stealth Labs USA Peptides section, offering premium research-grade peptides.
Please log in to write SURVODUTIDE 10MG review.
CLASSIFICATION: REGENERATIVE PEPTIDE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 4–6 HOURS
DOSAGE: 200–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 7 DAYS
DOSAGE: 0.25-0.5 MG WEEKLY, TITRATE AS NEEDED
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: TIRZEPATIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (20 MG/VIAL)
ACTIVE HALF-LIFE: ~5 DAYS
DOSAGE: 2.5 - 5 MG/WEEK (RESEARCH USE ONLY)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS USA
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: REGENERATIVE PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN BETA 4
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2–3 HOURS
DOSAGE: 2–5 MG TWICE WEEKLY (LOADING), THEN ONCE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (R-HGH)
ACTIVE SUBSTANCE: SOMATROPIN
FORM: 1 KIT (10 VIALS x 36 IU/VIAL)
ACTIVE HALF-LIFE: ~ 3–4 HOURS
DOSAGE: 2-6 IU DAILY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): POSSIBLE AT HIGH DOSES
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!